{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:56:57Z","timestamp":1761973017907,"version":"build-2065373602"},"reference-count":35,"publisher":"Japanese Society of Veterinary Science","issue":"11","funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K06480"],"award-info":[{"award-number":["20K06480"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K05613"],"award-info":[{"award-number":["23K05613"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1292\/jvms.25-0314","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T22:08:38Z","timestamp":1758146918000},"page":"1221-1226","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of motor deterioration in a cynomolgus macaque with neuronal ceroid lipofuscinosis type 2 disease using two behavioral analyses"],"prefix":"10.1292","volume":"87","author":[{"given":"Yoshiko","family":"MUNESUE","sequence":"first","affiliation":[{"name":"Division of Clinical Medicine, Department of Neurology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiko","family":"ONO","sequence":"additional","affiliation":[{"name":"Department of Veterinary Associated Science, Faculty of Veterinary Medicine, Okayama University of Science University, Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohide","family":"AGEYAMA","sequence":"additional","affiliation":[{"name":"Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"YAGAMI","sequence":"additional","affiliation":[{"name":"Laboratory Animal Resource Center, University of Tsukuba, Ibaraki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"ISHII","sequence":"additional","affiliation":[{"name":"Division of Clinical Medicine, Department of Neurology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"TAMAOKA","sequence":"additional","affiliation":[{"name":"Division of Clinical Medicine, Department of Neurology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"YASUTOMI","sequence":"additional","affiliation":[{"name":"Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Japan"},{"name":"Department of Molecular and Experimental Medicine, Mie University Graduate School of Medicine, Edobashi 2-174, Tsu, Mie 514-8507, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"SHIMOZAWA","sequence":"additional","affiliation":[{"name":"Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Anderson GW, Goebel HH, Simonati A.  2013. Human pathology in NCL. <i>Biochim Biophys Acta<\/i> 1832: 1807\u20131826.","DOI":"10.1016\/j.bbadis.2012.11.014"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Awano T, Katz ML, O\u2019Brien DP, Sohar I, Lobel P, Coates JR, Khan S, Johnson GC, Giger U, Johnson GS.  2006. A frame shift mutation in canine TPP1 (the ortholog of human CLN2) in a juvenile Dachshund with neuronal ceroid lipofuscinosis. <i>Mol Genet Metab<\/i> 89: 254\u2013260.","DOI":"10.1016\/j.ymgme.2006.02.016"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Fietz M, AlSayed M, Burke D, Cohen-Pfeffer J, Cooper JD, Dvo\u0159\u00e1kov\u00e1 L, Giugliani R, Izzo E, Jahnov\u00e1 H, Lukacs Z, Mole SE, Noher de Halac I, Pearce DA, Poupetova H, Schulz A, Specchio N, Xin W, Miller N.  2016. Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis. <i>Mol Genet Metab<\/i> 119: 160\u2013167.","DOI":"10.1016\/j.ymgme.2016.07.011"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Gardner E, Bailey M, Schulz A, Aristorena M, Miller N, Mole SE.  2019. Mutation update: Review of TPP1 gene variants associated with neuronal ceroid lipofuscinosis CLN2 disease. <i>Hum Mutat<\/i> 40: 1924\u20131938.","DOI":"10.1002\/humu.23860"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Geraets RD, Langin LM, Cain JT, Parker CM, Beraldi R, Kovacs AD, Weimer JM, Pearce DA.  2017. A tailored mouse model of CLN2 disease: A nonsense mutant for testing personalized therapies. <i>PLoS One<\/i> 12: e0176526.","DOI":"10.1371\/journal.pone.0176526"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Haltia M.  2003. The neuronal ceroid-lipofuscinoses. <i>J Neuropathol Exp Neurol<\/i> 62: 1\u201313.","DOI":"10.1093\/jnen\/62.1.1"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Haltia M, Goebel HH.  2013. The neuronal ceroid-lipofuscinoses: a historical introduction. <i>Biochim Biophys Acta<\/i> 1832: 1795\u20131800.","DOI":"10.1016\/j.bbadis.2012.08.012"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Huber RJ, Hughes SM, Liu W, Morgan A, Tuxworth RI, Russell C.  2020. The contribution of multicellular model organisms to neuronal ceroid lipofuscinosis research. <i>Biochim Biophys Acta Mol Basis Dis<\/i> 1866: 165614.","DOI":"10.1016\/j.bbadis.2019.165614"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Imbert C, Bezard E, Guitraud S, Boraud T, Gross CE.  2000. Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey. <i>J Neurosci Methods<\/i> 96: 71\u201376.","DOI":"10.1016\/S0165-0270(99)00184-3"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Katz ML, Coates JR, Sibigtroth CM, Taylor JD, Carpentier M, Young WM, Wininger FA, Kennedy D, Vuillemenot BR, O\u2019Neill CA.  2014. Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease). <i>J Neurosci Res<\/i> 92: 1591\u20131598.","DOI":"10.1002\/jnr.23423"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Koie H, Shibuya H, Sato T, Sato A, Nawa K, Nawa Y, Kitagawa M, Sakai M, Takahashi T, Yamaya Y, Yamato O, Watari T, Tokuriki M.  2004. Magnetic resonance imaging of neuronal ceroid lipofuscinosis in a border collie. <i>J Vet Med Sci<\/i> 66: 1453\u20131456.","DOI":"10.1292\/jvms.66.1453"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kurlan R, Kim MH, Gash DM.  1991. Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys: assessment with a new rating scale for monkey parkinsonism. <i>Mov Disord<\/i> 6: 111\u2013118.","DOI":"10.1002\/mds.870060205"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kuwamura M, Nakagawa M, Nabe M, Yamate J, Inoue M, Satoh H, Yamato O.  2009. Neuronal ceroid-lipofuscinosis in a Japanese domestic shorthair cat. <i>J Vet Med Sci<\/i> 71: 665\u2013667.","DOI":"10.1292\/jvms.71.665"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Le NM, Parikh S.  2012. Late infantile neuronal ceroid lipofuscinosis and dopamine deficiency. <i>J Child Neurol<\/i> 27: 234\u2013237.","DOI":"10.1177\/0883073811419261"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mahmood F, Fu S, Cooke J, Wilson SW, Cooper JD, Russell C.  2013. A zebrafish model of CLN2 disease is deficient in tripeptidyl peptidase 1 and displays progressive neurodegeneration accompanied by a reduction in proliferation. <i>Brain<\/i> 136: 1488\u20131507.","DOI":"10.1093\/brain\/awt043"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Mart\u00ednez-Mart\u00edn P, Gil-Nagel A, Gracia LM, G\u00f3mez JB, Mart\u00ednez-Sarri\u00e9s J, Bermejo F. The Cooperative Multicentric Group. 1994. Unified Parkinson\u2019s Disease Rating Scale characteristics and structure. <i>Mov Disord<\/i> 9: 76\u201383.","DOI":"10.1002\/mds.870090112"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Miao SB, Guo H, Kong DX, Zhao YY, Pan SH, Jiang Y, Gao X, Wu XH.  2022. Case report: Analysis of novel compound heterozygous <i>TPP1<\/i> variants in a Chinese patient with neuronal ceroid lipofuscinosis type 2. <i>Front Genet<\/i> 13: 937485.","DOI":"10.3389\/fgene.2022.937485"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Mizukami K, Kawamichi T, Koie H, Tamura S, Matsunaga S, Imamoto S, Saito M, Hasegawa D, Matsuki N, Tamahara S, Sato S, Yabuki A, Chang HS, Yamato O.  2012. Neuronal ceroid lipofuscinosis in Border Collie dogs in Japan: clinical and molecular epidemiological study (2000\u20132011). <i>ScientificWorldJournal<\/i> 2012: 383174.","DOI":"10.1100\/2012\/383174"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Munesue Y, Ageyama N, Kimura N, Takahashi I, Nakayama S, Okabayashi S, Katakai Y, Koie H, Yagami KI, Ishii K, Tamaoka A, Yasutomi Y, Shimozawa N.  2023. Cynomolgus macaque model of neuronal ceroid lipofuscinosis type 2 disease. <i>Exp Neurol<\/i> 363: 114381.","DOI":"10.1016\/j.expneurol.2023.114381"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Murray SJ, Almuqbel MM, Felton SA, Palmer NJ, Myall DJ, Shoorangiz R, Ella A, Keller M, Palmer DN, Melzer TR, Mitchell NL.  2023. Progressive MRI brain volume changes in ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinosis. <i>Brain Commun<\/i> 5: fcac339.","DOI":"10.1093\/braincomms\/fcac339"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Nakayama H, Uchida K, Shouda T, Uetsuka K, Sasaki N, Goto N.  1993. Systemic ceroid-lipofuscinosis in a Japanese domestic cat. <i>J Vet Med Sci<\/i> 55: 829\u2013831.","DOI":"10.1292\/jvms.55.829"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Nibe K, Nakayama H, Uchida K.  2010. Comparative study of cerebellar degeneration in canine neuroaxonal dystrophy, cerebellar cortical abiotrophy, and neuronal ceroid-lipofuscinosis. <i>J Vet Med Sci<\/i> 72: 1495\u20131499.","DOI":"10.1292\/jvms.10-0072"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Nickel M, Simonati A, Jacoby D, Lezius S, Kilian D, Van de Graaf B, Pagovich OE, Kosofsky B, Yohay K, Downs M, Slasor P, Ajayi T, Crystal RG, Kohlsch\u00fctter A, Sondhi D, Schulz A.  2018. Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study. <i>Lancet Child Adolesc Health<\/i> 2: 582\u2013590.","DOI":"10.1016\/S2352-4642(18)30179-2"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Nickel M, Schulz A.  2022. Natural history studies in NCL and their expanding role in drug development: Experiences from CLN2 disease and relevance for clinical trials. <i>Front Neurol<\/i> 13: 785841.","DOI":"10.3389\/fneur.2022.785841"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Nita DA, Mole SE, Minassian BA.  2016. Neuronal ceroid lipofuscinoses. <i>Epileptic Disord<\/i> 18 S2: 73\u201388.","DOI":"10.1684\/epd.2016.0844"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Primate Society of Japan. 1986. Guiding Principles for animal experiments using nonhuman primates. <i>Primate Rep<\/i> 2: 111\u2013113.","DOI":"10.2354\/psj.2.111"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Sanders DN, Kanazono S, Wininger FA, Whiting REH, Flournoy CA, Coates JR, Castaner LJ, O\u2019Brien DP, Katz ML.  2011. A reversal learning task detects cognitive deficits in a Dachshund model of late-infantile neuronal ceroid lipofuscinosis. <i>Genes Brain Behav<\/i> 10: 798\u2013804.","DOI":"10.1111\/j.1601-183X.2011.00718.x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Sleat DE, Donnelly RJ, Lackland H, Liu CG, Sohar I, Pullarkat RK, Lobel P.  1997. Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. <i>Science<\/i> 277: 1802\u20131805.","DOI":"10.1126\/science.277.5333.1802"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Sleat DE, Wiseman JA, El-Banna M, Kim KH, Mao Q, Price S, Macauley SL, Sidman RL, Shen MM, Zhao Q, Passini MA, Davidson BL, Stewart GR, Lobel P.  2004. A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration. <i>J Neurosci<\/i> 24: 9117\u20139126.","DOI":"10.1523\/JNEUROSCI.2729-04.2004"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Steinfeld R, Heim P, von Gregory H, Meyer K, Ullrich K, Goebel HH, Kohlsch\u00fctter A.  2002. Late infantile neuronal ceroid lipofuscinosis: quantitative description of the clinical course in patients with CLN2 mutations. <i>Am J Med Genet<\/i> 112: 347\u2013354.","DOI":"10.1002\/ajmg.10660"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Swier VJ, White KA, Johnson TB, Sieren JC, Johnson HJ, Knoernschild K, Wang X, Rohret FA, Rogers CS, Pearce DA, Brudvig JJ, Weimer JM.  2022. A novel porcine model of CLN2 Batten disease that recapitulates patient phenotypes. <i>Neurotherapeutics<\/i> 19: 1905\u20131919.","DOI":"10.1007\/s13311-022-01296-7"},{"key":"32","unstructured":"32. The National Academies Press. 2011. Institute for Laboratory Animal Research. Guide for the care and use of laboratory animals, 8th ed, Washington (DC)."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Uchida A, Sasaguri H, Kimura N, Tajiri M, Ohkubo T, Ono F, Sakaue F, Kanai K, Hirai T, Sano T, Shibuya K, Kobayashi M, Yamamoto M, Yokota S, Kubodera T, Tomori M, Sakaki K, Enomoto M, Hirai Y, Kumagai J, Yasutomi Y, Mochizuki H, Kuwabara S, Uchihara T, Mizusawa H, Yokota T.  2012. Non-human primate model of amyotrophic lateral sclerosis with cytoplasmic mislocalization of TDP-43. <i>Brain<\/i> 135: 833\u2013846.","DOI":"10.1093\/brain\/awr348"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Worgall S, Kekatpure MV, Heier L, Ballon D, Dyke JP, Shungu D, Mao X, Kosofsky B, Kaplitt MG, Souweidane MM, Sondhi D, Hackett NR, Hollmann C, Crystal RG.  2007. Neurological deterioration in late infantile neuronal ceroid lipofuscinosis. <i>Neurology<\/i> 69: 521\u2013535.","DOI":"10.1212\/01.wnl.0000267885.47092.40"},{"key":"35","unstructured":"35. Yoshida M, Shishikura K, Saito K, Takahashi R, Ozumi T, Yajima K, Fukuyama Y.  1992. Long-term survival in a case of neuronal ceroid-lipofuscinosis (late infantile form): Clinical, electrophysiological and neuroradiological diagnosis from early juvenile form. <i>J Tokyo Wom Med Univ<\/i> 62: 1300\u20131310."}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/87\/11\/87_25-0314\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:16:59Z","timestamp":1761970619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/87\/11\/87_25-0314\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.25-0314","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"type":"print","value":"0916-7250"},{"type":"electronic","value":"1347-7439"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"25-0314"}}